Abstract:Background: T lymphocytes and matrix metalloproteinase (MMP) play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the details of the mechanisms involved are unclear. The aims of this study were to investigate the changes in interferon-gamma (IFN-gamma), interleukin-4 (IL-4), MMP-9, MMP-12 and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels in a smoke-induced COPD rat model and the therapeutic effects of glucocorticoids and N-acetylcysteine. Methods: Male Wistar rats were exposed to cigarette smoke for 3.5 months. Budesonide or N-acetylcysteine was given in the last month. Lung function was measured at the end of the study. IL-4 and IFN-gamma levels were then determined in bronchoalveolar lavage fluid and lung tissue samples by enzyme-linked immunosorbent assay. The expression of MMP-9, MMP-12 and TIMP-1 mRNA in lung tissue was determined by RT-PCR. Results: In comparison with the control group, rats exposed to smoke had a significant increase in IL-4 and MMP-12 levels and a significant decrease in IFN-gamma levels. In addition, the IL-4/IFN-gamma ratio and MMP-12/TIMP-1 ratio were both higher. At the same time, the ratio of forced expiratory volume in 0.3 second to forced vital capacity (FEV(0.3)/FVC) and dynamic compliance (C(dyn)) decreased and expiratory resistance (Re) increased. By measuring pulmonary mean linear intercept and mean alveolar numbers, obvious emphysematous changes were observed in the smoke exposed group. After treatment with budesonide, IL-4 and MMP-12 decreased and IFN-gamma increased. The IL-4/IFN-gamma ratio returned to normal, though the MMP-12/TIMP-1 ratio remained unchanged. FEV(0.3)/FVC was significantly higher and Re was significantly lower than that in untreated smoke exposed rats. No significant differences were found in pulmonary mean linear intercept and mean alveolar numbers. After treatment with N-acetylcysteine, IFN-gamma increased and the IL-4/IFN-gamma ratio decreased. The MMP-12/TIMP-1 ratio remained unchanged. Re and C(dyn) both improved obviously. No significant differences were found in pulmonary mean linear intercept and mean alveolar numbers. Correlation analysis indicated that IL-4 levels in lung tissue correlated negatively with FEV(0.3)/FVC (r = -0.53, P = 0.001), IFN-gamma levels in lung tissue correlated negatively with Re (r = -0.63, P = 0.000) and positively with C(dyn) (r = 0.44, P = 0.009), and that the IL-4/IFN-gamma ratio correlated negatively with FEV(0.3)/FVC (r = -0.44, P = 0.010) and C(dyn) (r = -0.42, P = 0.015) and positively with Re (r = 0.58, P = 0.000). Finally, MMP-12 correlated negatively with FEV(0.3)/FVC (r = -0.36, P = 0.026). Conclusions: Cigarette smoke exposure increases IL-4 levels and decreases IFN-gamma levels. This may be the result of smoke-induced changes in lung function. Budesonide can mitigate the changes in IL-4 and IFN-gamma levels induced by smoke exposure. N-acetylcysteine has no effect on IL-4, but increases IFN-gamma levels and brings the IL-4/IFN-gamma ratio back to normal. Cigarette smoke can also promote MMP-12 gene expression and elevate the MMP-12/TIMP-1 ratio. This effect may play a role in smoke-induced emphysema. Budesonide and N-acetylcysteine do not alter the MMP-12/TIMP-1 ratio in this study when given in the late phase of smoke exposure.

The effect and the mechanism of phosphodiesterase 4 on MUC5AC expression in cigarette smoking-induced COPD rat lung tissue

Research progress of roflumilast in the treatment of chronic obstructive pulmonary disease

Role of HIF-1α in phosphodiesterase-4 inhibitor roflumilast mediated effect on MUC5AC expression in human bronchial epithelial

Zl-n-91, a Selective Phosphodiesterase 4 Inhibitor, Suppresses Inflammatory Response in a COPD-like Rat Model.

Effects of Glucocorticoids on Interleukin-4/Interferon-γ and Matrix Metalloproteinases in Rat Models of Smoke-Induced Chronic Obstructive Pulmonary Disease

Effects of Tiotropium Bromide on Airway Inflammation in a Rat Model with COPD

Experimentmental Study on Inhibition of Ambroxol in Airway Remodeling of Chronic Obstructive Pulmonary Disease Rat Models

Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model

Chronic treatment of β-blocker inhibited mucus hypersecretion and MUC5AC expression exposed to cigarette smoking through β-arrestin2–ERK1/2 pathway

Effect of Nourishing Qi, Activating Blood Circulation and Dispersing Phlegm Recipe on the Pathology of Chronic Obstructive Pulmonary Disease Rat Models

[Effects of simvastatin on airway inflammation and airway mucus hypersecretion in rats with chronic obstructive pulmonary disease].

Inhibition of β-adrenoceptors alleviated mucus secretion and emphysema in cigarette smoke exposed rat model

Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats

Effect of Smoking Cessation on Airway Inflammation of Rats with Chronic Bronchitis

[Alveolar macrophages in rats with chronic obstructive pulmonary disease (COPD) promotes proliferation, mucin and inflammatory factors secretion of airway epithelial cells and its mechanism]

Effect of SB203580 on Cigarette Smoke Exposure to Asthmatic Rats

Effect of ozone exposure on airway inflammation and NF-κ B expression in lung tissue of COPD rats

Effect of Curcumin on the Expression of IL-1β and IL-17 in a Rat Model of Chronic Obstructive Pulmonary Disease

[Down-regulation of HMGB1 expression ameliorates the progression of COPD in mice by inhibiting inflammatory response and epithelial mesenchymal transition]

Effects and mechanism of Radix Paeoniae Rubra on airway remodeling of cigarette smoke mediated-COPD model rats

The Roll of Alveolar Macrophages in Airway Inflammation of COPD Rats